Atlas Trials

Carcinoma, Neuroendocrine

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Carcinoma, Neuroendocrine

RecordFirmDate
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430)Travera Inc2022-07-15
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC) (NCT05237934)National Cancer Institute (NCI)2022-04-25
Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s (NCT04488263)National Cancer Institute (NCI)2020-11-24
Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types (NCT03012620)UNICANCER2017-07-05
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385)Hoffmann-La Roche2017-03-17
Personalized PRRT of Neuroendocrine Tumors (NCT02754297)CHU de Quebec-Universite Laval2016-04-12
An Open Label, Single-Centre, Pilot Study of Everolimus With EBRT for the Treatment of mNET Liver Metastasis (NCT02205515)Sunnybrook Health Sciences Centre2016-03-01
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers (NCT02487095)National Cancer Institute (NCI)2015-07-30
Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery (NCT02315625)National Cancer Institute (NCI)2015-04-08
KPT-330 to Treat Poorly Differentiated Lung and Gastroenteropancreatic Tumors (NCT02250885)Gabrail Cancer Center Research2014-08-01
A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours (NCT01876771)AHS Cancer Control Alberta2014-04-29
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers (NCT00926640)National Cancer Institute (NCI)2009-07-01
TheraSphere for the Treatment of Liver Metastases (NCT00511862)Boston Scientific Corporation2007-01-01
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract (NCT00353015)M.D. Anderson Cancer Center2003-03-01

Track Carcinoma, Neuroendocrine automatically

Every clearance here is in the API, with alerts when new ones post.